SEC Form 4 · accession 0001179110-15-016518
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 18, 2015 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Dec 14, 2015 | G | 76,280 | $0.00 | D | 1,394,153 | D | |
| Common shares without par value | Dec 16, 2015 | M | 438,000 | $21.2194 | A | 1,832,153 | D | |
| Common shares without par value | Dec 16, 2015 | S | 296,778 | $46.00 | D | 1,535,375 | D | |
| Common shares without par value | Dec 16, 2015 | S | 14,781 | $46.005 | D | 1,520,594 | D | |
| Common shares without par value | Dec 16, 2015 | S | 400 | $46.0075 | D | 1,520,194 | D | |
| Common shares without par value | Dec 16, 2015 | S | 89,114 | $46.01 | D | 1,431,080 | D | |
| Common shares without par value | Dec 16, 2015 | S | 2,921 | $46.015 | D | 1,428,159 | D | |
| Common shares without par value | Dec 16, 2015 | S | 12,150 | $46.02 | D | 1,416,009 | D | |
| Common shares without par value | Dec 16, 2015 | S | 2,617 | $46.025 | D | 1,413,392 | D | |
| Common shares without par value | Dec 16, 2015 | S | 200 | $46.0275 | D | 1,413,192 | D | |
| Common shares without par value | Dec 16, 2015 | S | 14,439 | $46.03 | D | 1,398,753 | D | |
| Common shares without par value | Dec 16, 2015 | S | 1,100 | $46.035 | D | 1,397,653 | D | |
| Common shares without par value | Dec 16, 2015 | S | 1,300 | $46.04 | D | 1,396,353 | D | |
| Common shares without par value | Dec 16, 2015 | S | 300 | $46.045 | D | 1,396,053 | D | |
| Common shares without par value | Dec 16, 2015 | S | 1,900 | $46.05 | D | 1,394,153 | D | |
| Common shares without par valueF2 | Dec 14, 2015 | G | 630 | $0.00 | A | 630 | I | By wife |
| Common shares without par valueF2 | Dec 14, 2015 | G | 300 | $0.00 | A | 8,643 | I | By son |
| Common shares without par valueF2 | Dec 14, 2015 | G | 300 | $0.00 | A | 8,552 | I | By son |
| Common shares without par valueF2 | Dec 14, 2015 | G | 630 | $0.00 | D | 0 | I | By wife |
| Common shares without par valueF2 | Dec 14, 2015 | G | 175 | $0.00 | A | 8,818 | I | By son |
| Common shares without par valueF2 | Dec 14, 2015 | G | 280 | $0.00 | A | 8,832 | I | By son |
| Common shares without par valueF1 | holding | — | — | — | 28,369 | I | Profit Sharing Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $21.2194 | Dec 16, 2015 | M | 438,000 | D | Feb 17, 2009 | Feb 16, 2016 | Common shares | 438,000 | 0 | D |
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of December 15, 2015.
- F2The reporting person disclaims beneficial ownership of all securities held by his wife and sons.
- F3Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).